Product NDC: | 54868-6091 |
Proprietary Name: | Taclonex Scalp |
Non Proprietary Name: | calcipotriene and betamethasone dipropionate |
Active Ingredient(s): | .643; 50 mg/g; ug/g & nbsp; calcipotriene and betamethasone dipropionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-6091 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022185 |
Marketing Category: | NDA |
Start Marketing Date: | 20091210 |
Package NDC: | 54868-6091-0 |
Package Description: | 1 BOTTLE in 1 CARTON (54868-6091-0) > 60 g in 1 BOTTLE |
NDC Code | 54868-6091-0 |
Proprietary Name | Taclonex Scalp |
Package Description | 1 BOTTLE in 1 CARTON (54868-6091-0) > 60 g in 1 BOTTLE |
Product NDC | 54868-6091 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | calcipotriene and betamethasone dipropionate |
Dosage Form Name | SUSPENSION |
Route Name | TOPICAL |
Start Marketing Date | 20091210 |
Marketing Category Name | NDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE |
Strength Number | .643; 50 |
Strength Unit | mg/g; ug/g |
Pharmaceutical Classes | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |